Poseida Therapeutics

$6.37 0.00% ($0.00)

Get ready to invest

About Poseida Therapeutics

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company has discovered and are developing a broad portfolio of product candidates in a variety of indications based on its core platforms, including its non-viral piggyBac deoxyribonucleic acid (DNA) Modification System, Cas-CLOVER site-specific gene editing system and nanoparticle- and adeno-associated virus (AAV)-based gene delivery technologies. The Company’s product candidate portfolio includes P-BCMA-101, P-PSMA-101, P-BCMA-ALLO1, P-MUC1C-ALL01, Dual CAR, P-OTC-101 and P-MMUT-101.

Popular Stocks	Price	Change
Snap SNAP	$55.14 8.44%	8.44%
Intel INTC	$49.46 0.7%	0.7%
Itau ITUB	$4.13 0.24%	0.24%
Petrobras PBR	$9.95 1.64%	1.64%
Banco Bradesco Pref Shares BBD	$3.6 1.64%	1.64%
Ford F	$16.28 0.31%	0.31%
Cleveland-Cliffs CLF	$23.85 7.19%	7.19%
Apple AAPL	$148.69 0.52%	0.52%
Ambev ABEV	$2.62 1.95%	1.95%